Application Nr Approved Date Route Status External Links
BLA021665 None Subcutaneous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Amphadase ® Is Indicated As An Adjuvant • In Subcutaneous Fluid Administration For Achieving Hydration ( 1.1 ) • To Increase Absorption And Dispersion Of Other Injected Drugs ( 1.2 ) • In Subcutaneous Urography For Improving Resorption Of Radiopaque Agents ( 1.3 ) 1.1 Subcutaneous Fluid Administration Amphadase ® Is Indicated As An Adjuvant In Subcutaneous Fluid Administration For Achieving Hydration. 1.2 Dispersion And Absorption Of Injected Drugs Amphadase ® Is Indicated As An Adjuvant To Increase The Dispersion And Absorption Of Other Injected Drugs. 1.3 Subcutaneous Urography Amphadase ® Is Indicated As An Adjunct In Subcutaneous Urography For Improving Resorption Of Radiopaque Agents.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Hyaluronidase

Comments